These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 16397268)

  • 1. Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells.
    Roda JM; Parihar R; Magro C; Nuovo GJ; Tridandapani S; Carson WE
    Cancer Res; 2006 Jan; 66(1):517-26. PubMed ID: 16397268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines.
    Roda JM; Joshi T; Butchar JP; McAlees JW; Lehman A; Tridandapani S; Carson WE
    Clin Cancer Res; 2007 Nov; 13(21):6419-28. PubMed ID: 17962339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
    Oliva A; Kinter AL; Vaccarezza M; Rubbert A; Catanzaro A; Moir S; Monaco J; Ehler L; Mizell S; Jackson R; Li Y; Romano JW; Fauci AS
    J Clin Invest; 1998 Jul; 102(1):223-31. PubMed ID: 9649576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-21 enhances NK cell activation in response to antibody-coated targets.
    Roda JM; Parihar R; Lehman A; Mani A; Tridandapani S; Carson WE
    J Immunol; 2006 Jul; 177(1):120-9. PubMed ID: 16785506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection.
    Fehniger TA; Herbein G; Yu H; Para MI; Bernstein ZP; O'Brien WA; Caligiuri MA
    J Immunol; 1998 Dec; 161(11):6433-8. PubMed ID: 9834136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma.
    Yoong KF; Afford SC; Jones R; Aujla P; Qin S; Price K; Hubscher SG; Adams DH
    Hepatology; 1999 Jul; 30(1):100-11. PubMed ID: 10385645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines.
    Dorner BG; Scheffold A; Rolph MS; Huser MB; Kaufmann SH; Radbruch A; Flesch IE; Kroczek RA
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6181-6. PubMed ID: 11972057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients.
    Parihar R; Nadella P; Lewis A; Jensen R; De Hoff C; Dierksheide JE; VanBuskirk AM; Magro CM; Young DC; Shapiro CL; Carson WE
    Clin Cancer Res; 2004 Aug; 10(15):5027-37. PubMed ID: 15297404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
    Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
    J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tick saliva inhibits the chemotactic function of MIP-1alpha and selectively impairs chemotaxis of immature dendritic cells by down-regulating cell-surface CCR5.
    Oliveira CJ; Cavassani KA; Moré DD; Garlet GP; Aliberti JC; Silva JS; Ferreira BR
    Int J Parasitol; 2008 May; 38(6):705-16. PubMed ID: 18023445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
    J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis.
    Taub DD; Sayers TJ; Carter CR; Ortaldo JR
    J Immunol; 1995 Oct; 155(8):3877-88. PubMed ID: 7561094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral expression of MIP-1beta induces antitumor responses in a pre-established tumor model through chemoattracting T cells and NK cells.
    Luo X; Yu Y; Liang A; Xie Y; Liu S; Guo J; Wang W; Qi R; An H; Zhang M; Xu H; Guo Z; Cao X
    Cell Mol Immunol; 2004 Jun; 1(3):199-204. PubMed ID: 16219168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice.
    Comes A; Di Carlo E; Musiani P; Rosso O; Meazza R; Chiodoni C; Colombo MP; Ferrini S
    Eur J Immunol; 2002 Jul; 32(7):1914-23. PubMed ID: 12115611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CCR5 expression by IL-12 through induction of beta-chemokines in human T lymphocytes.
    Wang J; Guan E; Roderiquez G; Norcross MA
    J Immunol; 1999 Dec; 163(11):5763-9. PubMed ID: 10570258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes.
    Roth SJ; Carr MW; Springer TA
    Eur J Immunol; 1995 Dec; 25(12):3482-8. PubMed ID: 8566041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. V gamma 9 V delta 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs--rituximab and trastuzumab.
    Tokuyama H; Hagi T; Mattarollo SR; Morley J; Wang Q; So HF; Moriyasu F; Nieda M; Nicol AJ
    Int J Cancer; 2008 Jun; 122(11):2526-34. PubMed ID: 18307255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.
    Luedke E; Jaime-Ramirez AC; Bhave N; Roda J; Choudhary MM; Kumar B; Teknos TN; Carson WE
    Surgery; 2012 Sep; 152(3):431-40. PubMed ID: 22770960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins.
    Maghazachi AA; al-Aoukaty A; Schall TJ
    J Immunol; 1994 Dec; 153(11):4969-77. PubMed ID: 7525719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.